3
Total investments
3
Early stage
0
Mid stage
0
Late stage
8y
Years active
Portfolio
3 investments ยท sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Observer and Seed Investor
May 2021
Valink Therapeutics focusses on synergistic and non-obvious target combinations to create novel multivalent bispecific antibody-drug conjugates (bsADCs) that transform the treatment of solid tumors and other indications.
Valink is a platform therapeutics company focussing on the discovery of bsADCs based out of Cambridge, MA and London, UK. The company is a VC-backed & Y Combinator (W21)-incubated spin-out of the University of Oxford, with over $20M total capital raised.
Seed Investor
Dec 2018
Regard, an innovative healthcare technology company, strives to bring world-class healthcare to everyone by closing the Clinical Insights Gap. Our leading Clinical Insights Platform empowers physicians to make better informed decisions that improve patient outcomes and increase hospital revenue.
Experience ยท 4 entries
All (4)
Investments (3)
Board (1)
2021
Board Observer and Seed Investor
May 2021
Valink Therapeutics focusses on synergistic and non-obvious target combinations to create novel multivalent bispecific antibody-drug conjugates (bsADCs) that transform the treatment of solid tumors and other indications.
Valink is a platform therapeutics company focussing on the discovery of bsADCs based out of Cambridge, MA and London, UK. The company is a VC-backed & Y Combinator (W21)-incubated spin-out of the University of Oxford, with over $20M total capital raised.
2018
Seed Investor
Dec 2018
Regard, an innovative healthcare technology company, strives to bring world-class healthcare to everyone by closing the Clinical Insights Gap. Our leading Clinical Insights Platform empowers physicians to make better informed decisions that improve patient outcomes and increase hospital revenue.
2016
Investment activity
2018โ2021 ยท 3 investments
Recent (last 2 years)Earlier
